Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[ancestry category]	Characteristics[age]	Characteristics[developmental stage]	Characteristics[sex]	Characteristics[disease]	Characteristics[cell type]	Characteristics[biological replicate]	Assay Name	Comment[fraction identifier]	Comment[technical replicate]	Comment[file uri]	Comment[instrument]	Comment[MS2 analyzer type]	Comment[MS2 analyzer type]	Comment[label]	Comment[cleavage agent details]	Comment[cleavage agent details]	Comment[modification parameters]	Comment[modification parameters]	Comment[modification parameters]	Comment[collision energy]	Comment[dissociation method]	Comment[precursor mass tolerance]	Comment[fragment mass tolerance]	Comment[precursor ion isolation]	Comment[data file]	factor value[disease]
PXD020557-Sample-1	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 1	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC10_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC10_E01.raw	ovarian cancer
PXD020557-Sample-2	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 2	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC1_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC1_E01.raw	ovarian cancer
PXD020557-Sample-3	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 3	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC2_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC2_E01.raw	ovarian cancer
PXD020557-Sample-4	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 4	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC3_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC3_E01.raw	ovarian cancer
PXD020557-Sample-5	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 5	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC4_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC4_E01.raw	ovarian cancer
PXD020557-Sample-6	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 6	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC5_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC5_E01.raw	ovarian cancer
PXD020557-Sample-7	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 7	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC6_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC6_E01.raw	ovarian cancer
PXD020557-Sample-8	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 8	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC7_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC7_E01.raw	ovarian cancer
PXD020557-Sample-9	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 9	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC8_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC8_E01.raw	ovarian cancer
PXD020557-Sample-10	Homo sapiens	plasma	not available	59.7(¡À15.4)Y	adult	female	ovarian cancer	plasma	1	run 10	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCC9_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCC9_E01.raw	ovarian cancer
PXD020557-Sample-11	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 11	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN10_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN10_E01.raw	normal
PXD020557-Sample-12	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 12	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN1_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN1_E01.raw	normal
PXD020557-Sample-13	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 13	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN2_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN2_E01.raw	normal
PXD020557-Sample-14	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 14	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN3_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN3_E01.raw	normal
PXD020557-Sample-15	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 15	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN4_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN4_E01.raw	normal
PXD020557-Sample-16	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 16	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN5_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN5_E01.raw	normal
PXD020557-Sample-17	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 17	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN6_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN6_E01.raw	normal
PXD020557-Sample-18	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 18	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN7_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN7_E01.raw	normal
PXD020557-Sample-19	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 19	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN8_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN8_E01.raw	normal
PXD020557-Sample-20	Homo sapiens	plasma	not available	55.6(¡À12.5)Y	adult	female	normal	plasma	1	run 20	1	1	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/12/PXD020557/20190314_OCN9_E01.raw	NT=Q Exactive Plus;AC=MS:1002634	NT=quadrupole ion trap;AC=MS:1000082	NT=orbitrap;AC=MS:1000484	NT=label free sample;AC=MS:1002038	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;TA=C;AC=UNIMOD:4;MT=Fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=Variable	NT=Acetyl;PP=N-term;AC=UNIMOD:1;MT=Variable	27% NCE	HCD	10 ppm	20 ppm	2 Da	20190314_OCN9_E01.raw	normal
